2-Thiazolamine, 4-(4-methoxyphenyl)-5-(3-pyridinyl)- → [4-(4-Methoxyphenyl)-5-(3-pyridyl)-1,3-thiazol-2-yl]amine hydrochloride

HRID 1062618

Reaktionsgleichung

Reaktionsgleichung von HRID 1062618
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([C:9]2[N:10]=[C:11]([NH2:20])[S:12][C:13]=2[C:14]2[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=2)=[CH:5][CH:4]=1.[ClH:21].CO>>[ClH:21].[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]([C:9]2[N:10]=[C:11]([NH2:20])[S:12][C:13]=2[C:14]2[CH:15]=[N:16][CH:17]=[CH:18][CH:19]=2)=[CH:7][CH:8]=1

Komponenten

3

Versuchsvorschrift

[4-(4-Methoxyphenyl)-5-(3-pyridyl)-1,3-thiazol-2-yl]amine (200 mg) was dissolved in 1% hydrochloric acid-methanol (3.2 mL) and the solvent was evaporated. The obtained crude crystals were recrystallized from methanol-ethyl acetate to give the title compound (180 mg, yield 80%).

Aufarbeitung

  1. customthe solvent was evaporated
  2. customThe obtained crude crystals
  3. customwere recrystallized from methanol-ethyl acetate

Quellen und Nachweise

ORD-Eintrag
ord-f1b5d51f519c45178c251dde334f60cd
Quelldatensatz
uspto-grants-2005_11
Patentnummer
US06962933B1

Verknüpfte Notizen

Wird geladen…